{"entity":{"id":"theodore-hong","kind":"person","name":"Theodore S. Hong","aka":[],"tldr":"Showed how radiation, including proton therapy, can be used in liver and pancreatic cancers previously considered unsuitable.","summary":"Theodore S. Hong is Director of Gastrointestinal Radiation Oncology at Massachusetts General Hospital Cancer Center. He is a radiation oncologist known for showing how radiation, including proton therapy, can be used in liver and pancreatic cancers previously considered unsuitable for it. His selected paper reports a multi-institutional phase 2 study of high-dose hypofractionated proton beam therapy in localised, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. He leads proton and stereotactic radiotherapy studies in hepatobiliary and pancreatic cancers and neoadjuvant chemoradiation combinations, including losartan-based stromal modulation.","asOf":"2026-09-08","links":[{"label":"MGH profile","url":"https://www.massgeneral.org/doctors/17557/theodore-hong"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Hong%20TS%5BAuthor%5D"}],"tags":[],"related":[],"cancers":["hcc","cholangiocarcinoma","pancreatic"],"sections":[],"technologies":["proton-therapy","sbrt"],"targets":[],"drugs":[],"companies":[],"institutions":["mgh"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Gastrointestinal Radiation Oncology","institutionId":"mgh","specialisms":["Proton therapy","Liver and pancreatic cancer radiation","Total neoadjuvant therapy"],"profiles":[{"label":"MGH profile","url":"https://www.massgeneral.org/doctors/17557/theodore-hong"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Hong%20TS%5BAuthor%5D"}],"papers":[{"title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","journal":"Journal of Clinical Oncology","year":2016,"url":"https://doi.org/10.1200/JCO.2015.64.2710","doi":"10.1200/JCO.2015.64.2710"}],"orcid":"0000-0001-8481-6581"},"route":"/people/theodore-hong/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"borderline-resectable-pdac","kind":"cancer","name":"Borderline resectable pancreatic ductal adenocarcinoma","route":"/cancers/borderline-resectable-pdac/"},{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"},{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"technology":[{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"sbrt","kind":"technology","name":"SBRT / SABR (stereotactic radiotherapy)","route":"/technologies/sbrt/"}],"institution":[{"id":"mgh","kind":"institution","name":"Massachusetts General Hospital Cancer Center","route":"/institutions/mgh/"}]}}